PAS
BIIB icon

Park Avenue Securities’s Biogen BIIB Stock Holding History

Park Avenue Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
+7,248
New +$1.39M 0.01% 774
2026
Q1 		– Sell
-3,030
Closed -$533K – 1533
2025
Q4 		$533K Sell
3,030
-417
-12% -$68.1K ﹤0.01% 1066
2025
Q3 		$483K Buy
3,447
+244
+8% +$33K ﹤0.01% 1200
2025
Q2 		$402K Buy
3,203
+137
+4% +$17.1K ﹤0.01% 1158
2025
Q1 		$420K Buy
3,066
+759
+33% +$109K 0.01% 903
2024
Q4 		$353K Sell
2,307
-323
-12% -$54.5K ﹤0.01% 1214
2024
Q3 		$510K Buy
2,630
+101
+4% +$21.1K 0.01% 956
2024
Q2 		$586K Buy
2,529
+193
+8% +$41.9K 0.01% 896
2024
Q1 		$504K Sell
2,336
-215
-8% -$50.4K 0.01% 943
2023
Q4 		$660K Sell
2,551
-281
-10% -$69K 0.01% 793
2023
Q3 		$728K Buy
+2,832
New +$757K 0.01% 691
2023
Q1 		– Sell
-1,698
Closed -$470K – 748
2022
Q4 		$470K Buy
1,698
+226
+15% +$63.8K 0.01% 797
2022
Q3 		$393K Buy
1,472
+166
+13% +$35.3K 0.01% 806
2022
Q2 		$266K Buy
1,306
+247
+23% +$50.5K 0.01% 966
2022
Q1 		$223K Buy
1,059
+209
+25% +$45.4K ﹤0.01% 1053
2021
Q4 		$204K Sell
850
-436
-34% -$112K ﹤0.01% 1057
2021
Q3 		$364K Buy
1,286
+55
+4% +$18K 0.01% 781
2021
Q2 		$426K Sell
1,231
-267
-18% -$80.9K 0.01% 696
2021
Q1 		$419K Buy
1,498
+280
+23% +$75.5K 0.01% 640
2020
Q4 		$298K Sell
1,218
-746
-38% -$192K 0.01% 688
2020
Q3 		$557K Buy
1,964
+85
+5% +$23.7K 0.02% 407
2020
Q2 		$503K Buy
1,879
+323
+21% +$97.1K 0.02% 393
2020
Q1 		$492K Buy
1,556
+515
+49% +$156K 0.04% 152
2019
Q4 		$309K Buy
1,041
+99
+11% +$27.5K 0.01% 457
2019
Q3 		$219K Buy
942
+39
+4% +$9.08K 0.01% 474
2019
Q2 		$211K Sell
903
-79
-8% -$18.2K 0.02% 247
2019
Q1 		$228K Sell
982
-32
-3% -$10.1K 0.01% 410
2018
Q4 		$338K Buy
1,014
+388
+62% +$124K 0.05% 106
2018
Q3 		$221K Buy
+626
New +$216K 0.04% 176

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Park Avenue Securities's BIIB Position: Q2 2026 in Review

Park Avenue Securities opened a new position in Biogen (BIIB) in Q2 2026: 7,248 shares worth $1.57M. The stake represents 0.01% of the portfolio and ranks #774 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in BIIB as recently as Q4 2025.

Park Avenue Securities first reported a position in BIIB in Q3 2018 and has held it in 29 quarters since. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Park Avenue Securities held 7,248 shares of Biogen worth $1.57M as of Q2 2026.
  • Biogen was a new Park Avenue Securities position in Q2 2026.
  • Biogen made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #774 holding.
  • Park Avenue Securities first reported a position in Biogen in Q3 2018 and has held it in 29 quarters since.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.